Rogers State University

Associate Degree Nursing Program

Required Drug Information

Student name: ERIN MCDANIEL

Date/ Clinical week: 11/02/2009- WEEK 2
Clinical faculty: Mrs. VAN GUNDY
Patient weight: 39.5 #
Patient age: 4
Patient allergies NKDA

1. Generic name of the drug: IBUPROFEN

2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
Children's Motrin
Chronic, symptomatic rheumatoid arthritis and osteoarthritis;
relief of mild to moderate pain; primary dysmenorrhea; reduction
of fever
For pain
Pain relief
Yes, pt had pain from constant cough. Pain was not present when
asked around an hour after administered.
Hypertension, history of GI ulceration; diabetes mellitus,
impaired hepatic or renal function, history of coronary artery
disease, angina, MI cardiac decompensation; chronic renal
failure, patients with SLE.
CNS: Headache, dizziness, light-headedness, anxiety, emotional
lability, fatigue, malaise, drowsiness, anxiety, confusion,
depression, aseptic meningitis. CV: Hypertension, palpitation,
congestive heart failure (patient with marginal cardiac function);
peripheral edema. Special Senses: Amblyopia (blurred vision,
decreased visual acuity, scotomas, changes in color vision);
nystagmus, visual-field defects; tinnitus, impaired hearing. GI:
Dry mouth, gingival ulcerations, dyspepsia, heartburn, nausea,
vomiting, anorexia, diarrhea, constipation, bloating, flatulence,
epigastric or abdominal discomfort or pain, GI ulceration, occult
blood loss. Hematologic: Thrombocytopenia, neutropenia,
hemolytic or aplastic anemia, leukopenia; decreased Hgb, Hct;
transitory rise in AST, ALT, serum alkaline phosphatase; rise in
(Ivy) bleeding time. GU: Acute renal failure, polyuria, azotemia,
cystitis, hematuria, nephrotoxicity, decreased creatinine
clearance. Skin: Maculopapular and vesicobullous skin eruptions,
erythema multiforme, pruritus, rectal itching, acne. Body as a
Whole: Fluid retention with edema, Stevens-Johnson syndrome,
toxic hepatitis, hypersensitivity reactions, anaphylaxis,
bronchospasm, serum sickness, SLE, angioedema.
90-180mg q4-6h up to 720mg/d
Yes, 7.5ml every 6 hrs prn for pain
Observation for apnea, cyanosis, dizziness, and nystagmus.
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Baseline and periodic evaluations of Hgb, renal and hepatic
function, and auditory and ophthalmologic examinations are
recommended in patients receiving prolonged or high-dose
therapy.
Discontinue med immediately and notify physician if apnea,
cyanosis, dizziness, and/or nystagmus is present in patient.
Notify physician immediately of passage of dark tarry stools,
"coffee ground" emesis, frankly bloody emesis, or other GI
distress, as well as blood or protein in urine, and onset of skin
rash, pruritus, jaundice.

Student name:
Date/ Clinical week:
Clinical faculty:
Patient weight:
Patient age:
Patient allergies
1. Generic name of the drug:
2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Rogers State University
Associate Degree Nursing Program
Required Drug Information
ERIN MCDANIEL
11/02/2009- Week 2
Mrs. VAN GUNDY
39.5#
4
NKDA
ACETAMINOPHEN
Tylenol Suspension 160/5
It provides temporary analgesia for mild to moderate pain. In
addition, acetaminophen lowers body temperature in individuals
with a fever.
If fever present.
To reduce fever
Pt did not receive. Fever was not present.
Repeated administration to patients with anemia, G6PD
deficiency, renal or hepatic disease; arthritic or rheumatoid
conditions affecting children <12 y; alcoholism; malnutrition;
thrombocytopenia; bone marrow depression, immunosuppression.
Body as a Whole: Negligible with recommended dosage; rash.
Acute poisoning: Anorexia, nausea, vomiting, dizziness, lethargy,
diaphoresis, chills, epigastric or abdominal pain, diarrhea; onset
of hepatotoxicity—elevation of serum transaminases (ALT, AST)
and bilirubin; hypoglycemia, hepatic coma, acute renal failure
(rare). Chronic ingestion: Neutropenia, pancytopenia, leukopenia,
thrombocytopenic purpura, hepatotoxicity in alcoholics, renal
damage.
180-270 mg q4-6h
Yes, 7.5ml q4-6 hrs prn for fever.
Monitor for hepatotoxicity, even with moderate acetaminophen
doses, especially in individuals with poor nutrition, and
poisoning.
n/a
Discontinue med immediately and notify physician if any signs of
hepatotoxicity signs present.
Do not use this medication without medical direction for: fever
persisting longer than 3 d, fever over 39.5° C (103° F), or
recurrent fever. Do not take other medications (e.g., cold
preparations) containing acetaminophen without medical advice;
overdosing and chronic use can cause liver damage and other
toxic effects.

Student name:
Date/ Clinical week:
Clinical faculty:
Patient weight:
Patient age:
Patient allergies
1. Generic name of the drug:
2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Rogers State University
Associate Degree Nursing Program
Required Drug Information
ERIN MCDANIEL
11/02/2009
VAN GUNDY
39.5#
4
NKDA
AZITHROMYCIN
Zithromax
Acute bacterial sinusitis and community acquired pneumonia
Community acquired pneumonia
To clear up pneumonia
Not after day 2. Pt’s pneumonia has gotten worse.
Toxicity
CNS: Headache, dizziness. GI: Nausea, vomiting, diarrhea,
abdominal pain; hepatotoxicity, mild elevations in liver function
tests.
180 mg on day 1, then 90 mg for 4 more days (max: 250 mg/d)
No, 200 mg po every day (dose slightly over, but under daily
max)
Monitor for and report loose stools or diarrhea, since
pseudomembranous colitis must be ruled out.
n/a
Discontinue med and notify physician if any signs of diarrhea,
nausea, or vomiting occur.
Direct sunlight (UV) exposure should be minimized
during therapy with drug. Report onset of loose stools
or diarrhea.
Rogers State University

Student name:
Date/ Clinical week:
Clinical faculty:
Patient weight:
Patient age:
Patient allergies
1. Generic name of the drug:
2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Associate Degree Nursing Program
Required Drug Information
ERIN MCDANIEL
11/02/2009- Week 2
Mrs. Van Gundy
39.5#
4
NKDA
LEVALBUTEROL HYDROCHLORIDE
Xopenex
Treatment or prevention of bronchospasm in patients with
reversible obstructive airway disease.
Treatment of bronchospasms.
Open up airway to allow patient to breathe better.
Yes, patient was able to breathe better.
Toxicity
Body as a Whole: Allergic reactions, flu syndrome, pain. CNS:
Migraine, dizziness, nervousness, tremor, anxiety. CV:
Tachycardia. GI: Dyspepsia. Respiratory: Increased cough, viral
infection, rhinitis, sinusitis, turbinate edema, paradoxical
bronchospasm. Endocrine: Increase in serum glucose.
Inhalation 0.31 mg by nebulization t.i.d. every 6–8 h (max: 0.63
mg every 6 hours)
Yes, 0.63mg q6 hrs
Monitor blood pressure, heart rate, and respiratory status.
n/a
Discontinue med immediately and notify physician if
chest pains or palpitations, swelling of the eyelids,
tongue, lips, or face; increased wheezing or difficulty
breathing become present.
Seek medical advice immediately if a previously effective
dose becomes ineffective. Do not use drug more frequently
than prescribed. Exercise caution with hazardous activities;
dizziness and vertigo are possible side effects. Check with
physician before taking OTC cold medication.

Student name:
Date/ Clinical week:
Clinical faculty:
Patient weight:
Patient age:
Patient allergies
1. Generic name of the drug:
2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Rogers State University
Associate Degree Nursing Program
Required Drug Information
ERIN MCDANIEL
11/02/2009- Week 2
VAN GUNDY
39.5#
4
NKDA
CEFTRIAXONE SODIUM
Rocephin
Infections caused by susceptible organisms in lower respiratory
tract, skin and skin structures, urinary tract, bones and joints; also
intra-abdominal infections, pelvic inflammatory disease,
uncomplicated gonorrhea, meningitis, and surgical prophylaxis.
Infections caused by susceptible organisms in lower respiratory
tract
To clear up pneumonia
No, X-Ray showed negative interval chest impression on 11-01-
09. On 11-03-09 X-Ray showed developing Right Middle Lobe
Pneumonitis.
Toxicity
Body as a Whole: Pruritus, fever, chills, pain, induration at IM
injection site; phlebitis (IV site). GI: Diarrhea, abdominal cramps,
pseudomembranous colitis, biliary sludge. Urogenital: Genital
pruritus; moniliasis.
900-1350 mg/day in 2 divided doses
No, 500 mg IVPB every 24 hours (under dose, Patient also
receiving Zithromax.
Determine history of hypersensitivity reactions to
cephalosporins and penicillins and history of other
allergies, particularly to drugs, before therapy is
initiated. Note IV injection sites for signs of phlebitis
(redness, swelling, pain). Watch for petechiae,
ecchymotic areas, epistaxis, or any unexplained
bleeding. Ceftriaxone appears to alter vitamin K–
producing gut bacteria; therefore, hypoprothrombinemic
bleeding may occur. Check for fever if diarrhea occurs.
Incidence of antibiotic-produced pseudomembranous
colitis is higher than with most cephalosporins.
Culture and sensitivity tests before initiation of therapy and
periodically during therapy. Initial culture and sensitivity results
were not back.
Discontinue med immediately and notify physician if
hypersensitivity observed.
Report any signs of bleeding. Report loose stools or
diarrhea promptly.

Student name:
Date/ Clinical week:
Clinical faculty:
Patient weight:
Patient age:
Patient allergies
1. Generic name of the drug:
2. Trade name of the drug:
3. Indications for use of the drug:
4. For which of the above
indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:
8. Common adverse reactions/side
effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?
13. What special nursing
interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
Rogers State University
Associate Degree Nursing Program
Required Drug Information
ERIN MCDANIEL
11/02/2009- Week 2
Mrs. VAN GUNDY
39.5#
4
NKDA
PREDNISONE
n/a
Used in treatment of myasthenia gravis and inflammatory
conditions and as an immunosuppressant.
As an immunosuppressant
To build up patient’s immune system
N/A, does not appear to be working since Patient’s status seems
to have gotten worse.
Toxicity
CNS: Euphoria, headache, insomnia, confusion, psychosis. CV:
CHF, edema. GI: Nausea, vomiting, peptic ulcer.
Musculoskeletal: Muscle weakness, delayed wound healing,
muscle wasting, osteoporosis, aseptic necrosis of bone,
spontaneous fractures. Endocrine: Cushingoid features, growth
suppression in children, carbohydrate intolerance, hyperglycemia.
Special Senses: Cataracts. Hematologic: Leukocytosis.
Metabolic: Hypokalemia.
18-36 mg/day
Yes, 15mg/5ml Suspension> 5ml po BID
Check and record BP during dose stabilization period at least 2
times daily. Report an ascending pattern.
n/a
Report any changes in mood and behavior, emotional stability,
sleep pattern, or psychomotor activity to physician.
Take drug as prescribed and do not alter dosing regimen
or stop medication without consulting physician. Be
aware that a slight weight gain with improved appetite is
expected, but after dosage is stabilized, a sudden slow
but steady weight increase [2 kg (5 lb) per wk] should be
reported to physician. Report symptoms of GI distress
to physician and do not self-medicate to find relief. Do
not use aspirin or other OTC drugs unless they are
prescribed specifically by the physician.
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?
 Rogers State University
Associate Degree Nursing Program
Required Drug Information

Student name:
Date/ Clinical week: /
Clinical faculty:
Patient weight:
Patient age:
Patient allergies

1. Generic name of the drug:

2. Trade name of the drug:
3. Indications for use of the drug:

4. For which of the above

indications is your patient
receiving the drug?
5. Expected therapeutic effects of
the drug for your patient:
6. Has the drug produced the
expected effect in this patient?
How?
7. Life threatening adverse
reactions/side effects:

8. Common adverse reactions/side

effects:
9. What is the normal dose range of
the medication for this patient?
10. Is this patient's dose within the
normal range?
11. What special nursing assessments
are required for patients receiving
this medication?
12. What lab tests are monitored
related to use of this medication?

13. What special nursing

interventions are required for
patients receiving this
medication?
14. What special teaching is required
for patients receiving this
medication?